A look inside Berea as the Browns are back in town for Phase One

Inside the Cross Country Mortgage Campus, Browns players began workouts in phase one of the offseason program.

Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of ...
The Manila Times

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annu…

Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median time on treatment ...

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in ...
Agri-Pulse

China never delivered on many Phase One ag promises – and has backslid since

President Donald Trump, joined by Chinese Vice Premier Liu He, sign the U.S.-China Phase One trade agreement in 2020. (White House photo) Farm organizations are warning the Trump administration that ...
The Manila Times

Hinge Bio Announces First Subject Dosed in Phase 1 Trial of HB2198, a Novel B cell Depleting Agent, for Treating Autoimmune Disease

First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers.
abcnews4

Phase one of the Lowcountry Lowline could be ready in eight months, officials say

CHARLESTON, S.C. (WCIV) — Charleston city staff and Lowcountry Lowline organizers say phase one of the monumental Lowcountry Lowline project could be complete in eight months' time. On Thursday, a ...
UroToday

PSMA and Beyond 2026: Review of Phase 1/2 Compounds Recently Published

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. Jeremie Calais discussing a review of phase 1/2 compounds recently published. Without question, there ...